Articulo
Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer
Oncology Reports
Registro en:
1140417
1140417
Autor
Cifuentes, Federico F
Valenzuela, Rodrigo H
Contreras, Héctor R
Castellón-Vera, Enrique Alejandro
Institución
Resumen
Metastatic prostate cancer (mPCa) is one of the most prevalent cancers in men worldwide. The main cause of death in these patients is androgen-resistant metastatic disease. Surgery of the primary tumor has been avoided in these patients as there is no st Regular FONDECYT FONDECYT